Vor Biopharma (VOR) News

Express News | Vor Biopharma Inc. - Files for Mixed Shelf; Size Not Disclosed - SEC Filing

BreakingsSep 5 04:31

Vor Bio To Participate in Upcoming September Conferences

BOSTON, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that management will

GlobeNewswireSep 1 20:00

Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Definium Therapeutics (DFTX) and IDEAYA Biosciences (IDYA)

TipRanksAug 31 21:50

US Stock Market Close | US Treasury intervenes to support long-term bonds, lifting all three major indices; Moderna surges, igniting a rally in the biopharmaceutical sector, with Merck & Co up over 12% and the S&P Biotechnology ETF rising nearly 6%; Bitco

The S&P 500 closed up 0.21% at 7,707.98, the Nasdaq Composite rose 0.16% to 26,331.09, and the Dow Jones Industrial Average gained 0.22% to 53,463.05, ending a three-day losing streak for all three major indices. Moderna surged 176.97% to hit a record high, while Merck & Co jumped 13%, leading the healthcare sector's gains in the S&P; meanwhile, semiconductor and AI momentum stocks suffered heavy losses, with chip ETFs falling a cumulative 7.7% over two days.

wallstreetcnAug 20 07:02

Citi Maintains Vor Biopharma(VOR.US) With Buy Rating, Maintains Target Price $50

Citi analyst Geoff Meacham maintains $Vor Biopharma(VOR.US)$ with a buy rating, and maintains the target price at $50.According to TipRanks data, the analyst has a success rate of 59.6% and a total

Futu NewsAug 14 00:33

Citi Remains a Buy on Vor Biopharma (VOR)

TipRanksAug 13 23:55

Vor Biopharma Is Maintained at Neutral by Wedbush

Vor Biopharma Is Maintained at Neutral by

Dow JonesAug 13 00:15

Wedbush Maintains Vor Biopharma(VOR.US) With Hold Rating, Raises Target Price to $27

Wedbush analyst Martin Fan maintains $Vor Biopharma(VOR.US)$ with a hold rating, and adjusts the target price from $18 to $27.According to TipRanks data, the analyst has a success rate of 87.2% and

Futu NewsAug 12 22:31

Wells Fargo Issues a Buy Rating on Vor Biopharma (VOR)

TipRanksAug 12 18:58

Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), AnaptysBio (ANAB) and Erasca (ERAS)

TipRanksAug 12 18:40

Vor Biopharma Reports Q2 Results

Seeking AlphaAug 12 12:48

UPDATE: Vor Biopharma Q2 Adj. EPS $(0.80) Misses $(0.70) Estimate

Vor Biopharma (NASDAQ:VOR) reported quarterly losses of $(0.80) per share which missed the analyst consensus estimate of $(0.70) by 14.29 percent. This is a 98.17 percent increase over losses of $(43.

BenzingaAug 12 05:30

Wedbush Adjusts Price Target on Vor Biopharma to $27 From $18, Keeps Neutral Rating

Vor Biopharma (VOR) has an average rating of buy and mean price target of $37.88, according to analysts polled by FactSet.Price: 23.20, Change: -0.18, Percent Change: -0.75

MT NewswiresAug 11 22:58

Vor Biopharma Shares Drop After Q2 Results

Vor Biopharma (VOR) shares were down 1.2% in Tuesday trading after the company reported its Q2 results.The company reported a Q2 net loss of $1.16 per diluted share, narrower than a loss of $251.24

MT NewswiresAug 11 22:05

Earnings Flash (VOR) Vor Biopharma Posts Q2 Net Loss $1.16 a Share, Vs. FactSet Est of $0.70 Loss

09:34 AM EDT, 08/11/2026 (MT Newswires) -- Earnings Flash (VOR) Vor Biopharma Posts Q2 Net Loss $1.16 a Share, vs. FactSet Est of $0.70 LossPrice: 23.05, Change: -0.32, Percent Change: -1.39

MT NewswiresAug 11 21:34

10-Q: Vor Biopharma | 10-Q: Q2 2026 Earnings Report

SECAug 11 21:31

Vor Biopharma: Pro-forma Cash and Investment Balance of $514.5 M Expected to Provide Runway Into Early 2029 >VOR

Vor Biopharma: Pro-forma Cash and Investment Balance of $514.5 M Expected to Provide Runway Into Early 2029 >

Dow JonesAug 11 21:31

Express News | Vor Biopharma Q2 Net Income USD -62.8 Million Vs. IBES Estimate USD -35.7 Million

BreakingsAug 11 21:30

Express News | Vor Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update

BreakingsAug 11 21:30

Vor Biopharma Adds Industry Veteran David Zaccardelli to Board

TipRanksJul 8 04:31